Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01323933 · ClinicalTrials.gov registry record · Phase 1
First-in-human Study of AB0024 to Evaluate Safety and Tolerability in Adults With Advanced Solid Tumors
A Phase 1 study, sponsored by Gilead Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT01323933: Completed Phase 1 study, sponsored by Gilead Sciences.
NCT01323933 is a Phase 1 study that has completed, run by Gilead Sciences. The registered enrollment target is 32 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01323933, a Phase 1 study, has completed, sponsored by Gilead Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
Analysis of safety, tolerability, and PK data will provide information that will guide future development of AB0024.
Interventions
- DRUG AB0024
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-03 |
| Phase | Phase 1 |
What the finished NCT01323933 record still lists
NCT01323933 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 1 intervention - of which AB0024 is the first listed.
NCT01323933 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01323933 about?
NCT01323933 is a clinical study titled "First-in-human Study of AB0024 to Evaluate Safety and Tolerability in Adults With Advanced Solid Tumors". Analysis of safety, tolerability, and PK data will provide information that will guide future development of AB0024.
What is the current status of trial NCT01323933?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2010-06. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01323933?
The interventions under investigation include: AB0024 (DRUG).
Who is sponsoring clinical trial NCT01323933?
This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01323933's enrollment target sits among peer trials
32 1296th of 2000 higher than 679 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia